What is the Mangalam Drugs And Organics Ltd share price today?

The share price of NSE:MANGALAM-EQ on 01 Oct 2026 (as of 15:04:11 IST) is ₹29.01.

What is the NSE:MANGALAM-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:MANGALAM-EQ 52 week high low range shows a high of ₹73.9 and a low of ₹22.8.

What is the Mangalam Drugs And Organics Ltd market cap?

As on 01 Oct 2026, Mangalam Drugs And Organics Ltd market cap is ₹485927000.

What is the shareholding pattern of Mangalam Drugs And Organics Ltd Stock?

The shareholding pattern of Mangalam Drugs And Organics Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 35.65% Foreign Institutional Investors (FII): 0.11% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 64.24% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Mangalam Drugs And Organics Ltd?

The Price-to-Earnings (PE) ratio of Mangalam Drugs And Organics Ltd is 0, and the Price-to-Book (PB) ratio is 0.4575, as on 01 Oct 2026.

Mangalam Drugs And Organics Share Price

29.14-0.07 (-0.24%)

-56.43% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

1 Week

1 Month

3 Month

6 Month

YTD

1 Year

5 Year

10 Year

Max

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

No results found

About

Mangalam Drugs and Organics Limited is an India-based company engaged in the manufacturing of chemicals such as active pharma ingredients (API) perfumery disperse dye intermediates bulk drugs and bulk drugs Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

MANGALAMNSE

LTP

1W Low

1W High

Market cap (₹)

1769.9+8.9 (0.51%)

1722

1855

4,24,202Cr

10064+400 (4.14%)

9621.50

10064

2,64,141Cr

4650+70 (1.53%)

4532

4675

1,74,402Cr

2323+79 (3.52%)

2206.10

2441.90

1,26,811Cr

1240.6+56.2 (4.75%)

1182

1254.20

1,23,685Cr

1368.3+23.3 (1.73%)

1336.70

1368.30

1,11,868Cr

1396.9+38.9 (2.86%)

1357

1396.90

1,11,650Cr

2475+5.7 (0.23%)

2457.90

2528

1,02,196Cr

1694.5+34.6 (2.08%)

1647.20

1697.40

96,951Cr

2015.9+26 (1.31%)

1974

2033.80

91,301Cr

29.14-0.08 (-0.27%)

28.34

29.75

46Cr

Mangalam Drugs And Organics Share Price

29.14-0.07 (-0.24%)

-56.43% past 1 Year

Open a free Demat account in minutes to start investing and screening .

Mangalam Drugs And Organics Share Price

29.14-0.07 (-0.24%)

-56.43% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years-

Last year-27%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year-761%

Stock Price CAGR

10 years-15%

5 years-26%

3 years-34%

1 year-56%

Return on Equity

10 years-13%

5 years-13%

3 years-13%

Last year-37%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	-	-27%
-	-	-	-761%
-15%	-26%	-34%	-56%
-13%	-13%	-13%	-37%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

MANGALAM

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,769.9	₹424202 Cr	38.68	8.29	58.23	₹11479 Cr
10,064	₹264141 Cr	90.3	34.04	128.41	₹2568 Cr
4,650	₹174402 Cr	82.11	14.04	106.21	₹2163 Cr
2,323	₹126811 Cr	94.64	8.17	33.94	₹889 Cr
1,240.6	₹123685 Cr	27.41	9.42	62.53	₹5040 Cr
1,368.3	₹111868 Cr	39.95	11.08	59.2	₹4196 Cr
1,396.9	₹111650 Cr	38.54	10.86	52.6	₹3879 Cr
2,475	₹102196 Cr	45.57	17.23	76.26	₹1913 Cr
1,694.5	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
2,015.9	₹91301 Cr	16.51	30.95	154.35	₹5333 Cr
29.14	₹46 Cr	—	-4.83	-12.89	-₹44 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
₹57 Cr	₹67 Cr	₹58 Cr	₹50 Cr	₹57 Cr	₹73 Cr	₹89 Cr	₹80 Cr	₹77 Cr	₹102 Cr	₹97 Cr
₹11 L	₹9 L	₹11 L	₹3 L	₹14 L	₹47 L	₹14 L	₹14 L	₹2 L	₹5 L	₹20,000
₹57 Cr	₹67 Cr	₹59 Cr	₹50 Cr	₹57 Cr	₹73 Cr	₹89 Cr	₹80 Cr	₹77 Cr	₹102 Cr	₹97 Cr
₹60 Cr	₹78 Cr	₹64 Cr	₹57 Cr	₹66 Cr	₹68 Cr	₹84 Cr	₹75 Cr	₹72 Cr	₹94 Cr	₹94 Cr
₹1 Cr	-₹6 Cr	-₹1 Cr	-₹3 Cr	-₹4 Cr	₹10 Cr	₹9 Cr	₹9 Cr	₹8 Cr	₹12 Cr	₹7 Cr
₹4 Cr	₹3 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr
-₹7 Cr	-₹13 Cr	-₹10 Cr	-₹12 Cr	-₹13 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹59 L	₹4 Cr	₹4 L
-₹8 Cr	-₹13 Cr	-₹10 Cr	-₹7 Cr	-₹14 Cr	₹6 L	₹1 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹50 L

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Revaluation reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024
—	—	—
₹16 Cr	₹16 Cr	₹16 Cr
₹87 Cr	₹133 Cr	₹120 Cr
₹80 Cr	₹126 Cr	₹120 Cr
₹7 Cr	₹7 Cr	₹0
₹103 Cr	₹149 Cr	₹136 Cr
₹4 Cr	₹9 Cr	₹12 Cr
₹4 Cr	₹53 L	₹91 L
₹5 Cr	₹10 Cr	₹12 Cr
₹3 Cr	₹7 Cr	₹8 Cr
₹15 Cr	₹26 Cr	₹34 Cr
—	—	—
₹76 Cr	₹98 Cr	₹66 Cr
₹25 Cr	₹20 Cr	₹22 Cr
₹95 Cr	₹71 Cr	₹75 Cr
₹1 Cr	₹2 Cr	₹99 L
₹197 Cr	₹192 Cr	₹164 Cr
₹315 Cr	₹366 Cr	₹334 Cr
₹10 Cr	₹35 Cr	₹12 Cr
₹109 Cr	₹88 Cr	₹95 Cr
—	—	—
₹299 Cr	₹288 Cr	₹261 Cr
₹144 Cr	₹126 Cr	₹114 Cr
₹155 Cr	₹163 Cr	₹148 Cr
₹0	₹1 Cr	₹0
₹44,000	₹44,000	₹44,000
₹44,000	₹44,000	₹44,000
₹28 L	₹2 Cr	₹2 Cr
₹159 Cr	₹167 Cr	₹158 Cr
—	—	—
₹103 Cr	₹139 Cr	₹124 Cr
₹40 Cr	₹39 Cr	₹28 Cr
₹70 L	₹3 Cr	₹1 Cr
₹81 L	₹2 Cr	₹2 Cr
₹11 Cr	₹17 Cr	₹22 Cr
₹156 Cr	₹199 Cr	₹176 Cr
-₹41 Cr	₹7 Cr	₹12 Cr
₹315 Cr	₹366 Cr	₹334 Cr
₹61	₹90	₹86
₹61	₹90	₹86

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024
-₹49 Cr	₹5 Cr	₹4 Cr
₹33 Cr	₹31 Cr	₹14 Cr
₹20 Cr	₹7 Cr	-₹14 Cr
₹4 Cr	₹43 Cr	₹4 Cr
₹4 Cr	₹43 Cr	₹4 Cr
-₹12 Cr	-₹19 Cr	-₹12 Cr
₹6 Cr	-₹22 Cr	₹5 Cr
-₹2 Cr	₹1 Cr	-₹3 Cr
₹3 Cr	₹1 Cr	₹4 Cr
₹70 L	₹3 Cr	₹1 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Mangalam Drugs And Organics Share Price

29.14-0.07 (-0.24%)

-56.43% past 1 Year

Shareholding summary

Promoters

35.65%

FII

0.11%

DII

Others

64.24%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
35.65%	35.65%	35.65%	35.64%	50.30%	50.30%
0.11%	0.11%	0.32%	0.13%	0.11%	0.53%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
64.24%	64.24%	64.03%	64.23%	49.59%	49.17%

Bulk & block deals

Name

Neo Apex Venture Llp

Sanjay Kumar Saini

Jyotiprasad Taparia

Ashutosh Taparia

Shivkumar Damani

Sanjay Kumar Saini

Epitome Trading And Investments

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
03 Feb 2026	Sell	1.33 Cr	₹37.90	3.50 L	Bulk	2.211243	NSE
03 Feb 2026	Sell	40.20 L	₹38.01	1.06 L	Bulk	0.66813	BSE
02 Feb 2026	Purchase	1.49 Cr	₹32.68	4.56 L	Bulk	2.879374	NSE
13 Jan 2026	Sell	38.62 L	₹40.65	95 K	Bulk	0.600195	NSE
13 Jan 2026	Sell	63.96 L	₹42.64	1.50 L	Bulk	0.947676	NSE
12 Jan 2026	Sell	81.22 L	₹40.61	2 L	Bulk	1.263568	NSE
12 Jan 2026	Sell	33.30 L	₹40.61	82 K	Bulk	0.518056	NSE
09 Jan 2026	Purchase	36.83 L	₹38.77	95 K	Bulk	0.600195	BSE
09 Jan 2026	Sell	51.98 L	₹38.77	1.34 L	Bulk	0.846995	BSE
08 Jan 2026	Purchase	36.84 L	₹36.84	1 L	Bulk	0.631784	NSE

Insider trading & SAST

Client name

Shree Resbihari Trading And Investment Private Ltd

Aditya Ramniwas Dhoot

Shree Kishoriju Trading And Investments Private Ltd

Shree Kishoriju Trading And Investment Private Limited

Ajay Ramniwas Dhoot

Shree Rasbihari Trading And Investments Private Limited

Aditya Ramniwas Dhoot

Shree Kishoriju Trading And Investment Private Limited

Shri Jb Pharma Private Limited

Shree Kishoriju Trading And Investments Private Limited (Revised)

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
04 May 2026	Promoter	Pledge	—	—	0	—	1.73 L	16 Mar 2026	Release	0	SAST	Reg31	—
04 May 2026	Promoter	Pledge	—	—	0	—	89 K	16 Mar 2026	Release	0	SAST	Reg31	—
04 May 2026	Promoter	Pledge	0	—	0	—	1.50 K	06 Feb 2026	Release	0	SAST	Reg31	—
10 Apr 2026	Promoter Group	Revoke	0.009477	3.21	51.47 K	₹34.31	1.50 K	06 Feb 2026	Pledge Released	5,08,599	Insider Trading	—	Equity Shares
20 Mar 2026	Promoter Group	Revoke	0.871862	0.88	43.76 L	₹31.71	1.38 L	16 Mar 2026	Pledge Released	1,38,687	Insider Trading	—	Equity Shares
20 Mar 2026	Promoter	Revoke	1.092986	6.2	54.86 L	₹31.71	1.73 L	16 Mar 2026	Pledge Released	9,82,563	Insider Trading	—	Equity Shares
20 Mar 2026	Promoter Group	Revoke	0.562288	0.56	28.22 L	₹31.71	89 K	16 Mar 2026	Pledge Released	89,225	Insider Trading	—	Equity Shares
27 Feb 2026	Promoter	Revoke	0.868602	3.2	33.05 L	₹24.04	1.37 L	22 Dec 2025	Pledge Released	5,07,099	Insider Trading	—	Equity Shares
08 Dec 2025	Promoter Group	Invoke	10.740324	6	6.20 Cr	₹36.46	17 L	26 Nov 2025	Invocation Of Pledged	9,50,000	Insider Trading	—	Equity Shares
03 Dec 2025	Promoter	Invoke	4.605072	2.34	2.15 Cr	₹29.54	7.29 L	27 Nov 2025	Invocation Of Pledged	3,69,615	Insider Trading	—	Equity Shares

Mangalam Drugs And Organics Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Mangalam Drugs And Organics Share Price

Mangalam Drugs And Organics Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Mangalam Drugs And Organics Share Price

Mangalam Drugs And Organics Share Price

Mangalam Drugs And Organics Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Mangalam Drugs And Organics Share Price

Corporate Actions

Company details

Mangalam Drugs And Organics Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Mangalam Drugs And Organics Share Price

News

Mangalam Drugs And Organics flags Rs 15.57 crore loan defaults to banks

Mangalam Drugs & Organics informs about secretarial compliance report

Mangalam Drugs and Organics informs about newspaper advertisement

Mangalam Drugs&Org. reports Profit after tax of Rs -13.06 Crores, in the March 2026 quarter

Mangalam Drugs & Organics informs about revised disclosure

Mangalam Drugs & Organics informs about resignation of CS

Mangalam Drugs & Organics informs about disclosure

Mangalam Drugs & Organics informs about disclosure

Mangalam Drugs&Org. - Quaterly Results

Mangalam Drugs&Org. reports Profit after tax of Rs -9.78 Crores, in the December 2025 quarter

Investor Vijay Kedia Acquires 1.38 Lakh Shares in Mangalam Drugs at Rs 24.15 Each.

Mangalam Drugs & Organics secures Rs 15 crore export order for anti-malarial API, enhancing global business outlook.

Mangalam Drugs&Org. reports Profit after tax of 1.18 Crores, in the September 2025 quarter

NCLT Accepts Mangalam Drugs Merger Petition With Mangalam Laboratories and Shri JB Pharma

Mangalam Drugs and Organics gains on getting order from international client

Mangalam Drugs and Organics gets order from international client

Mangalam Drugs&Org. - Quaterly Results

Mangalam Drugs&Org. - Quaterly Results

Mangalam Drugs&Org. reports Profit after tax of Rs -13.73 Crores, in the June 2025 quarter

Mangalam Drugs&Org. reports Profit after tax of 15.10 Lakhs, in the March 2025 quarter

Mangalam Drugs And Organics Ltd Share Price Today

Mangalam Drugs And Organics Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator